3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
10
Melanoma
9
Neoplasm Metastasis
4
Clear-cell metastatic renal cell carcinoma
4
Carcinoma, Non-Small-Cell Lung
4
Prostatic Neoplasms
3
Myelodysplastic Syndromes
3
Leukemia, Myeloid, Acute
3
Carcinoma, Transitional Cell
3
Carcinoma, Basal Cell
3
Urogenital Neoplasms
2
Urinary Bladder Neoplasms
2
Urethral Neoplasms
2
Thyroid Neoplasms
2
Sarcoma
2
Penile Neoplasms
2
Ovarian Neoplasms
2
Nasopharyngeal Carcinoma
2
Lung Neoplasms
2
Histiocytoma, Malignant Fibrous
2
Glioblastoma
2
Carcinoma, Merkel Cell
2
Carcinoma, Endometrioid
2
Brain Neoplasms
2
Adenocarcinoma of Lung
2
Vulvar Neoplasms
1
Uveal Melanoma
1
Ureteral Neoplasms
1
Urachal adenocarcinoma
1
Triple Negative Breast Neoplasms
1
Interventions
Prednisone
5
Docetaxel
4
niraparib
2
enzalutamide
2
darolutamide
2
Pluvicto
2
Abiraterone Acetate
2
olaparib
1
ibrutinib
1
gedatolisib
1
gallium 68 PSMA-11
1
fludrocortisone acetate
1
cabazitaxel
1
abiraterone
1
Rosuvastatin Calcium
1
Pioglitazone
1
Omeprazole
1
JNJ-64619178
1
JNJ-64264681
1
Dexamethasone
1
(225)Ac-PSMA-617
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Prostatic Neoplasms, Castration-Resistant
×
CTLA-4 Antigen
×
90 days
×
Clear all
No trials found.